CEACAM1 and cancer: Extensive alternative splicing of CEACAM1 generates 2 divergent cytoplasmic domains (Ceacam1-S [short] or Ceacam1-L [long]) that confer specific intracellular signaling in epithelial, vascular, immune, and cancer cells (8–11).